T1	Fact 28 142	The sinoatrial node (SAN) is the natural pacemaker of the heart and has been studied in detail for over 100 years.
A1	Source T1 General_reference
T2	KT_cue 28 56	The sinoatrial node (SAN) is
R1	Cue Arg1:T2 Arg2:T1	
T4	Observation 143 300	In the second century the Greek philosopher and physiologist Claudius Galen observed the heart to continue beating independently when excised from the body.1
A2	Source T4 Non-integral_information_led_citation
T5	KT_cue 165 227	the Greek philosopher and physiologist Claudius Galen observed
R3	Cue Arg1:T5 Arg2:T4	
T6	Source_cue 298 300	.1
R4	Cue Arg1:T6 Arg2:T4	
T7	Analysis 301 536	It was not until the nineteenth century that the British physiologist Walter Gaskell demonstrated the myogenic origin of the heartbeat, tracing its contractile sequence to the 'sinus venosus' (SV) in the superior right atrium (RA).1, 2
A3	Source T7 Non-integral_information_led_citation
A4	Multiple_sources T7
T8	KT_cue 346 398	the British physiologist Walter Gaskell demonstrated
R5	Cue Arg1:T8 Arg2:T7	
T9	Source_cue 532 536	1, 2
R6	Cue Arg1:T9 Arg2:T7	
T14	Analysis 863 970	Keith concluded that the primitive structure in the sinus venosus must be the origin of the cardiac impulse
A10	Verb_noun T14 Certainty
A11	Source T14 Non-integral_information_led_citation
A12	Modality T14
A13	Certainty_Level T14 L3
T16	CL_cue 863 878	Keith concluded
R10	Cue Arg1:T16 Arg2:T14	
T15	KT_cue 863 878	Keith concluded
R9	Cue Arg1:T15 Arg2:T14	
T17	Modality_cue 884 936	the primitive structure in the sinus venosus must be
R11	Cue Arg1:T17 Arg2:T14	
T18	Fact 971 1032	and was subsequently credited for having discovered the SAN.4
A14	Source T18 Non-integral_information_led_citation
T19	KT_cue 975 1004	was subsequently credited for
R12	Cue Arg1:T19 Arg2:T18	
T20	Source_cue 1031 1032	4
R13	Cue Arg1:T20 Arg2:T18	
T21	Investigation 1033 1137	Since then, the SAN's histology, molecular features and electrophysiology have been extensively examined
A15	Source T21 Averred
T22	KT_cue 1045 1137	the SAN's histology, molecular features and electrophysiology have been extensively examined
R14	Cue Arg1:T22 Arg2:T21	
T24	Observation 1138 1255	and today we continue to add detail to our understanding of the mechanisms involved in SAN automaticity and function.
A16	Source T24 Averred
T25	KT_cue 1148 1176	we continue to add detail to
R16	Cue Arg1:T25 Arg2:T24	
T23	Fact 1257 1348	SAN dysfunction (SND) is seen in human disease causing it to beat too slowly or miss beats.
A17	Source T23 Averred
T26	KT_cue 1257 1289	SAN dysfunction (SND) is seen in
R15	Cue Arg1:T26 Arg2:T23	
T3	Source_cue 96 142	has been studied in detail for over 100 years.
R2	Cue Arg1:T3 Arg2:T1	
T27	Fact 1349 1431	SND is also known as sick sinus syndrome, prevalent in 0.03% of the UK population.
A18	Source T27 Averred
T28	KT_cue 1349 1355	SND is
R17	Cue Arg1:T28 Arg2:T27	
T29	Analysis 1432 1495	SND can lead to dizziness, loss of consciousness and collapse.5
A19	Source T29 Non-integral_information_led_citation
A20	Certainty_Level T29 L1
A21	Modality T29
T30	KT_cue 1432 1447	SND can lead to
R18	Cue Arg1:T30 Arg2:T29	
T31	CL_cue 1432 1447	SND can lead to
R19	Cue Arg1:T31 Arg2:T29	
T32	Modality_cue 1432 1447	SND can lead to
R20	Cue Arg1:T32 Arg2:T29	
T33	Source_cue 1494 1495	5
R21	Cue Arg1:T33 Arg2:T29	
T34	Fact 1496 1618	Currently this condition is treated by implanting an electronic pacemaker under the skin and feeding wires into the heart.
A22	Source T34 Averred
T35	KT_cue 1506 1534	this condition is treated by
R22	Cue Arg1:T35 Arg2:T34	
T36	Analysis 1619 1685	The prospect is often slightly daunting initially for the patient.
A23	Source T36 Averred
A24	Certainty_Level T36 L2
T37	CL_cue 1635 1640	often
R23	Cue Arg1:T37 Arg2:T36	
T38	KT_cue 1635 1640	often
R24	Cue Arg1:T38 Arg2:T36	
T39	Fact 1686 1807	However since their invention over 50 years ago, these devices have improved in their reliability, safety, cost and size.
A25	Source T39 Averred
T40	KT_cue 1735 1762	these devices have improved
R25	Cue Arg1:T40 Arg2:T39	
T41	Fact 1808 1861	They are the only effective treatment for SND to date
A26	Source T41 Non-integral_information_led_citation
T42	KT_cue 1808 1816	They are
R26	Cue Arg1:T42 Arg2:T41	
T43	Analysis 1862 1984	the latest data suggesting around 40,000 new pacemakers being fitted in the UK per year, about 20% of which were for SND.6
A27	Source T43 Non-integral_information_led_citation
A28	Certainty_Level T43 L1
T44	KT_cue 1862 1888	the latest data suggesting
R27	Cue Arg1:T44 Arg2:T43	
T45	CL_cue 1862 1888	the latest data suggesting
R28	Cue Arg1:T45 Arg2:T43	
T46	Source_cue 1983 1984	6
R29	Cue Arg1:T46 Arg2:T43	
T47	Fact 1986 2062	Nonetheless, electronic pacemakers still harbour several inherent drawbacks.
A29	Source T47 Averred
T48	KT_cue 1999 2034	electronic pacemakers still harbour
R30	Cue Arg1:T48 Arg2:T47	
T49	Fact 2063 2187	These include the need for indwelling hardware, the need to periodically replace generators via further invasive procedures,
A30	Source T49 Averred
T50	KT_cue 2063 2076	These include
R31	Cue Arg1:T50 Arg2:T49	
T51	KT_other 2188 2227	strong magnetic fields must be avoided,
A31	Source T51 Averred
A32	Modality T51
T52	Modality_cue 2188 2227	strong magnetic fields must be avoided,
A33	Modality T52
R32	Cue Arg1:T52 Arg2:T51	
T53	KT_cue 2188 2227	strong magnetic fields must be avoided,
R33	Cue Arg1:T53 Arg2:T51	
T54	Fact 2228 2281	they are unresponsive to the autonomic nervous system
A34	Source T54 Averred
T55	KT_cue 2228 2236	they are
R34	Cue Arg1:T55 Arg2:T54	
T56	Analysis 2282 2352	and thus have a limited response to demands from exercise and emotion,
A35	Source T56 Averred
A36	Certainty_Level T56 L4
T57	KT_cue 2286 2290	thus
R35	Cue Arg1:T57 Arg2:T56	
T58	CL_cue 2291 2295	have
R36	Cue Arg1:T58 Arg2:T56	
T59	Fact 2353 2473	and there is a small risk during implantation of causing significant bleeding, serious infection or puncturing the lung.
A37	Source T59 Averred
T60	KT_cue 2357 2365	there is
R37	Cue Arg1:T60 Arg2:T59	
T61	Analysis 2474 2590	Infection can necessitate the need for system extraction which can be complex and dangerous once embedded over time.
A38	Source T61 Averred
A39	Certainty_Level T61 L1
A40	Modality T61
T62	KT_cue 2474 2499	Infection can necessitate
R38	Cue Arg1:T62 Arg2:T61	
T63	CL_cue 2474 2499	Infection can necessitate
R39	Cue Arg1:T63 Arg2:T61	
T64	Modality_cue 2474 2499	Infection can necessitate
R40	Cue Arg1:T64 Arg2:T61	
T65	Modality_cue 2531 2543	which can be
R41	Cue Arg1:T65 Arg2:T61	
T66	Analysis 2591 2740	Furthermore, non-physiological pacing via the right ventricular apex long-term has been associated with ventricular dyssynchrony and cardiomyopathy.7
A41	Source T66 Non-integral_information_led_citation
A42	Certainty_Level T66 L2
T67	KT_cue 2604 2694	non-physiological pacing via the right ventricular apex long-term has been associated with
R42	Cue Arg1:T67 Arg2:T66	
T68	CL_cue 2604 2694	non-physiological pacing via the right ventricular apex long-term has been associated with
R43	Cue Arg1:T68 Arg2:T66	
T69	Source_cue 2739 2740	7
R44	Cue Arg1:T69 Arg2:T66	
T70	Fact 2742 2806	In the last 15 years, the concept of 'biopacemaking' has arisen.
A43	Source T70 Averred
T71	KT_cue 2764 2806	the concept of 'biopacemaking' has arisen.
R45	Cue Arg1:T71 Arg2:T70	
T72	Fact 2807 3100	Through advances in our knowledge of the molecular biology of the SAN and developments in gene therapy, we can now employ techniques such as the injection of engineered viruses into cardiac muscle to transduce pacemaker genes and create ectopic SAN-like pacemaker tissue anywhere in the heart.
A44	Source T72 Averred
A45	Modality T72
T73	KT_cue 2911 2928	we can now employ
R46	Cue Arg1:T73 Arg2:T72	
T74	Modality_cue 2911 2928	we can now employ
R47	Cue Arg1:T74 Arg2:T72	
T75	Analysis 3101 3301	Thus we have the potential to emulate the electronic pacemaker without the need for implantation of an external energy source or wires, whilst also being sensitive to the autonomic nervous system.8, 9
A46	Source T75 Non-integral_information_led_citation
A47	Certainty_Level T75 L1
A48	Multiple_sources T75
T76	KT_cue 3101 3105	Thus
R48	Cue Arg1:T76 Arg2:T75	
T77	CL_cue 3106 3127	we have the potential
R49	Cue Arg1:T77 Arg2:T75	
T78	Source_cue 3297 3301	8, 9
R50	Cue Arg1:T78 Arg2:T75	
T79	Analysis 3302 3432	There is also potential to repair dysfunctional pacemaker tissue by reverse engineering molecular abnormalities that occur in SND.
A49	Source T79 Averred
A50	Certainty_Level T79 L1
T80	KT_cue 3302 3325	There is also potential
R51	Cue Arg1:T80 Arg2:T79	
T81	CL_cue 3302 3325	There is also potential
R52	Cue Arg1:T81 Arg2:T79	
T82	Fact 3433 3643	However, biopacemaker research is still in its infancy and there are many challenges remaining including the search for the right gene targets, the best location for a biopacemaker and safe methods of delivery.
A51	Source T82 Averred
T83	KT_cue 3442 3466	biopacemaker research is
R53	Cue Arg1:T83 Arg2:T82	
T84	KT_other 3644 3791	The ideal biopacemaker should be robust, reliable, have similar physiological functional parameters to the SAN and respond to autonomic regulation.
A52	Source T84 Averred
T85	KT_cue 3644 3676	The ideal biopacemaker should be
R54	Cue Arg1:T85 Arg2:T84	
T86	Modality_cue 3644 3676	The ideal biopacemaker should be
R55	Cue Arg1:T86 Arg2:T84	
T87	Analysis 3792 3932	Once these challenges have been overcome, the biopacemaker could become a viable alternative therapeutic option to the electronic pacemaker.
A53	Source T87 Averred
A54	Modality T87
T88	KT_cue 3834 3863	the biopacemaker could become
R56	Cue Arg1:T88 Arg2:T87	
T89	CL_cue 3834 3863	the biopacemaker could become
R57	Cue Arg1:T89 Arg2:T87	
A55	Certainty_Level T87 L1
T90	Modality_cue 3834 3863	the biopacemaker could become
R58	Cue Arg1:T90 Arg2:T87	
T91	Fact 3983 4128	In mammals, the initial heart tube forms from two regions of the lateral plate mesoderm during the gastrulation stage of embryonic development.10
A56	Source T91 Non-integral_information_led_citation
T92	KT_cue 3995 4023	the initial heart tube forms
R59	Cue Arg1:T92 Arg2:T91	
T93	Source_cue 4126 4128	10
R60	Cue Arg1:T93 Arg2:T91	
T94	Fact 4129 4226	A caudal pool of progenitor cells remain which continue to extend both poles of the heart tube.11
A57	Source T94 Non-integral_information_led_citation
T95	KT_cue 4131 4169	caudal pool of progenitor cells remain
R61	Cue Arg1:T95 Arg2:T94	
T96	Source_cue 4224 4226	11
R62	Cue Arg1:T96 Arg2:T94	
T97	Fact 4227 4350	All cells in this primary myocardium are poorly differentiated and display slow automatic sinusoidal electrical activity.12
A58	Source T97 Non-integral_information_led_citation
T98	KT_cue 4227 4267	All cells in this primary myocardium are
R63	Cue Arg1:T98 Arg2:T97	
T99	Source_cue 4348 4350	12
R64	Cue Arg1:T99 Arg2:T97	
T100	Analysis 4351 4480	As the heart chambers develop, most cells differentiate and proliferate quickly into atrial and ventricular 'working myocardium'.
A59	Source T100 Averred
A60	Certainty_Level T100 L3
T101	KT_cue 4382 4386	most
R65	Cue Arg1:T101 Arg2:T100	
T102	CL_cue 4382 4386	most
R66	Cue Arg1:T102 Arg2:T100	
T103	Fact 4481 4602	They express high conductance gap junctions and ion channels, increased numbers of mitochondria and sarcomere components.
A61	Source T103 Averred
T104	KT_cue 4481 4493	They express
R67	Cue Arg1:T104 Arg2:T103	
T105	Fact 4603 4670	This leads to rapid impulse propagation but loss of automaticity.10
A62	Source T105 Non-integral_information_led_citation
T106	KT_cue 4603 4616	This leads to
R68	Cue Arg1:T106 Arg2:T105	
T107	Source_cue 4668 4670	10
R69	Cue Arg1:T107 Arg2:T105	
T108	Fact 4672 4738	Three discrete areas do not differentiate into working myocardium.
A63	Source T108 Averred
A64	Neg_CL T108
T109	KT_cue 4672 4713	Three discrete areas do not differentiate
R70	Cue Arg1:T109 Arg2:T108	
T110	Fact 4739 4805	These are the SV, the AV canal and the outflow tract (figure 1).12
A65	Source T110 Non-integral_information_led_citation
T111	KT_cue 4739 4748	These are
R71	Cue Arg1:T111 Arg2:T110	
T112	Source_cue 4803 4805	12
R72	Cue Arg1:T112 Arg2:T110	
T113	Fact 4806 4897	Instead these areas retain their primary character with slow automatic electrical activity.
A66	Source T113 Averred
T114	KT_cue 4814 4832	these areas retain
R73	Cue Arg1:T114 Arg2:T113	
T115	Fact 4898 4939	A dominating rhythm arises from the SV.13
A67	Source T115 Non-integral_information_led_citation
T116	KT_cue 4898 4929	A dominating rhythm arises from
R74	Cue Arg1:T116 Arg2:T115	
T117	Source_cue 4937 4939	13
R75	Cue Arg1:T117 Arg2:T115	
T122	Fact 5204 5332	Higher vertebrate animals go on to develop a more complex SAN within the SV and atrioventricular node (AVN) within the AV canal.
A70	Source T122 Averred
T123	KT_cue 5204 5238	Higher vertebrate animals go on to
R79	Cue Arg1:T123 Arg2:T122	
T124	Fact 5333 5450	Different species develop these to different extents, for example larger animals have evolved more defined systems.10
A71	Source T124 Non-integral_information_led_citation
T125	KT_cue 5333 5358	Different species develop
R80	Cue Arg1:T125 Arg2:T124	
T126	Source_cue 5448 5450	10
R81	Cue Arg1:T126 Arg2:T124	
T127	Fact 5452 5583	The differential developmental lineage of the cardiac conduction system (CCS) and working myocardium is directed by specific genes.
A72	Source T127 Averred
T128	KT_cue 5452 5567	The differential developmental lineage of the cardiac conduction system (CCS) and working myocardium is directed by
R82	Cue Arg1:T128 Arg2:T127	
T129	Fact 5584 5743	Nkx2-5 is a homeobox gene (homeobox genes are a family of genes that direct early structural embryonic development) that drives working myocardial development.
A73	Source T129 Averred
T130	KT_cue 5584 5593	Nkx2-5 is
R83	Cue Arg1:T130 Arg2:T129	
T131	Fact 5744 5888	By day 10.5 of embryonic development in mice Nkx2-5 is apparent in working myocardium, but absent from the sinus horns developing from the SV.14
A74	Source T131 Non-integral_information_led_citation
T132	KT_cue 5789 5798	Nkx2-5 is
R84	Cue Arg1:T132 Arg2:T131	
T133	Source_cue 5886 5888	14
R85	Cue Arg1:T133 Arg2:T131	
T134	Analysis 5889 6030	Nkx2-5 is thought to activate working myocardial genes such as Nppa and the high conductance gap junctions Connexin (Cx) 40 amongst others.14
A75	Source T134 Non-integral_information_led_citation
T135	KT_cue 5889 5909	Nkx2-5 is thought to
R86	Cue Arg1:T135 Arg2:T134	
A76	Certainty_Level T134 L2
T136	CL_cue 5889 5909	Nkx2-5 is thought to
R87	Cue Arg1:T136 Arg2:T134	
T137	Source_cue 6028 6030	14
R88	Cue Arg1:T137 Arg2:T134	
T138	Fact 6031 6209	Nkx2-5 also represses genes specific to CCS development such as the transcription factor Tbx3 and the pacemaker ion channel gene Hcn4 limiting the border of the developing CCS.14
A77	Source T138 Non-integral_information_led_citation
T139	KT_cue 6031 6052	Nkx2-5 also represses
R89	Cue Arg1:T139 Arg2:T138	
T140	Source_cue 6207 6209	14
R90	Cue Arg1:T140 Arg2:T138	
T141	Fact 6210 6319	Conversely Tbx3 present in the developing CCS represses Nppa and Cx40, the downstream atrial genes of Nkx2-5,
A78	Source T141 Non-integral_information_led_citation
A79	Multiple_sources T141
T142	KT_cue 6221 6265	Tbx3 present in the developing CCS represses
R91	Cue Arg1:T142 Arg2:T141	
T143	Analysis 6320 6412	and so the CCS and working myocardium become mutually exclusive with a defined border.14, 15
A80	Source T143 Non-integral_information_led_citation
A81	Certainty_Level T143 L4
T144	KT_cue 6324 6326	so
R92	Cue Arg1:T144 Arg2:T143	
T145	CL_cue 6327 6364	the CCS and working myocardium become
R93	Cue Arg1:T145 Arg2:T143	
T146	Source_cue 6406 6412	14, 15
R94	Cue Arg1:T146 Arg2:T143	
T147	Investigation 6414 6491	Transgenic mice were used to investigate the interactions of Nkx2-5 and Tbx3.
A82	Source T147 Averred
T148	KT_cue 6414 6442	Transgenic mice were used to
R95	Cue Arg1:T148 Arg2:T147	
T149	Observation 6492 6707	In one study Nkx2-5 deficient mice died at day 10, they failed to initiate chamber development, Nppa and Cx40 were not activated, and there was marked ectopic expression of Tbx3 and Hcn4 throughout the heart tube.14
A83	Source T149 Non-integral_information_led_citation
T150	KT_cue 6505 6531	Nkx2-5 deficient mice died
R96	Cue Arg1:T150 Arg2:T149	
T151	Source_cue 6705 6707	14
R97	Cue Arg1:T151 Arg2:T149	
T152	Observation 6708 6929	Tbx3 deficient mice died between day 11 and 13, but interestingly at day 11.5 a junction between Nkx2-5/Nppa/Cx40 positive and negative myocardium still formed at the SV, along with a SAN-like structure with Hcn4 present,
A84	Source T152 Non-integral_information_led_citation
T153	KT_cue 6708 6732	Tbx3 deficient mice died
R98	Cue Arg1:T153 Arg2:T152	
T10	Observation 537 862	In 1906, from a rented cottage in Kent turned laboratory, the Scottish anthropologist Sir Arthur Keith and his medical student Martin Flack microscopically identified remnants of "primitive fibres" within the SV with similar features to atrioventricular (AV) conduction tissue described earlier that year by Sunao Tawara.3, 4
A5	Source T10 Non-integral_information_led_citation
A6	Multiple_sources T10
T11	KT_cue 595 703	the Scottish anthropologist Sir Arthur Keith and his medical student Martin Flack microscopically identified
R7	Cue Arg1:T11 Arg2:T10	
T12	Source_cue 858 859	3
R8	Cue Arg1:T12 Arg2:T10	
T13	Analysis 4940 5117	The development of a conduction pathway via fast working myocardium interrupted by these slow primary tissues will eventually give rise to a recognisable electrocardiogram (ECG)
A7	Source T13 Non-integral_information_led_citation
A8	Certainty_Level T13 L2
T118	KT_cue 4940 5078	The development of a conduction pathway via fast working myocardium interrupted by these slow primary tissues will eventually give rise to
R76	Cue Arg1:T118 Arg2:T13	
T119	CL_cue 4940 5078	The development of a conduction pathway via fast working myocardium interrupted by these slow primary tissues will eventually give rise to
R77	Cue Arg1:T119 Arg2:T13	
T120	Modality_cue 4940 5078	The development of a conduction pathway via fast working myocardium interrupted by these slow primary tissues will eventually give rise to
R78	Cue Arg1:T120 Arg2:T13	
A9	Modality T13
T121	Fact 5118 5203	and this basic pathway is conserved in all vertebrates with multi-chambered hearts.12
A68	Source T121 Non-integral_information_led_citation
T158	KT_cue 5122 5153	this basic pathway is conserved
R102	Cue Arg1:T158 Arg2:T121	
T159	Source_cue 5201 5203	12
R103	Cue Arg1:T159 Arg2:T121	
A69	Citation_length T152 Extended
T154	Analysis 6930 6945	suggesting that
A85	Source T154 Non-integral_information_led_citation
A86	Verb_noun T154 Speech_act_communication
A87	Citation_length T154 Extended
A88	Certainty_Level T154 L1
T155	KT_cue 6930 6940	suggesting
R99	Cue Arg1:T155 Arg2:T154	
T156	CL_cue 6930 6940	suggesting
R100	Cue Arg1:T156 Arg2:T154	
T157	Verb_cue 6930 6945	suggesting that
R101	Cue Arg1:T157 Arg2:T154	
T160	Fact 6946 7040	Tbx3 is not required for initial definition but for later fine tuning of the CCS gene program.
A89	Source T160 Non-integral_information_led_citation
T161	KT_cue 6946 6966	Tbx3 is not required
R104	Cue Arg1:T161 Arg2:T160	
A90	Certainty_Level T7 L4
T162	CL_cue 346 398	the British physiologist Walter Gaskell demonstrated
R105	Cue Arg1:T162 Arg2:T7	
